… In this study, we estimate the risk of recurrence after incident venous thromboembolism, …
In this large nationwide cohort of patients with incident venous thromboembolism, our main …

… strength (C statistics) for predicting thromboembolism.An ideal validation cohort for a
thromboembolic risk scheme would be a large real world cohort of patients with atrial fibrillation, …

… against the risk of bleeding, in ‘real-world’ patient populations are needed. In the present
study, the risk of thromboembolism and bleeding in a ‘real-world’ nationwide cohort of AF …

… , whereas our cohort most likely also included patients with LVEF above 35%. … thromboembolic
risk from time of first time hospitalization for heart failure. Studies have suggested that risk …

… ‐based data on familial risks are limited. Objectives:To examine the familial risk of venous
thromboembolism. Methods:We undertook a nationwide study of a cohort of patients with deep …

… The potential refinement to thromboembolic risk stratification that may spring from subdividing
… of thromboembolism and anticoagulant-related bleeding in patients with atrial fibrillation. …

… risks of venous thromboembolism in cirrhotic patients in Taiwan to evaluate whether the risk
… were applied to compare the hazards of venous thromboembolism in the matched cohorts. …

… We performed a nationwide cohort study of the association between clinical RA disease
activity and VTE risk. We also compared VTE incidence in the RA population relative to matched …

… an independently increased absolute risk for bleeding … risk regardless of NSAID type (such
as selective COX-2 inhibitors or nonselective NSAIDs). Thromboembolic risk and the risk for …

… In an unselected nationwide cohort, we used multivariate Poisson regression models … -economic
data, and calendar year, to assess the risk of VTE associated with psoriasis. A total of …